StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$43.81M. The highest annual figure on record is -$22.58M in fiscal 2023.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$43.81M–
FY2024Dec 31, 2024-$38.32M–
FY2023Dec 31, 2023-$22.58M–
FY2022Dec 31, 2022-$32.83M–
FY2021Dec 31, 2021-$41.02M–
FY2020Dec 31, 2020-$52.18M–

More CASI Pharmaceuticals figures

See a number that looks wrong?